3.23.3 html 443 296 1 false 121 0 false 7 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.archtherapeutics.com/20220930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-statements-of-operations Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-statements-of-changes-in-stockholders-deficit-unaudited Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-statements-of-changes-in-stockholders-deficit-unauditedB1CC72E6-0744-4BE2-A712-3EB4315222DC Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-statements-of-cash-flows-unaudited Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 007 - Statement - Consolidated Balance Sheets Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-balance-sheets9373A129-6377-4E68-A493-6FAF1A881564 Consolidated Balance Sheets Statements 8 false false R9.htm 008 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-balance-sheets-parentheticals14DFA13C-C5A5-4A60-A65B-77CD8E455C24 Consolidated Balance Sheets (Parentheticals) Statements 9 false false R10.htm 009 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-statements-of-operations-unaudited Consolidated Statements of Operations (Unaudited) Statements 10 false false R11.htm 010 - Statement - Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-statements-of-changes-in-stockholders-deficit-unaudited764C407B-6C8F-4E94-82F9-AD14D58BDAF3 Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Statements 11 false false R12.htm 011 - Statement - Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-statements-of-changes-in-stockholders-deficit-unaudited3F853D83-EF06-49CE-9CE1-373E40D2C56C Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Statements 12 false false R13.htm 012 - Statement - Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-statements-of-changes-in-stockholders-deficit-unaudited4B06FC41-D0C0-4356-AA0F-F7EF8F2D4A9F Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Statements 13 false false R14.htm 013 - Statement - Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-statements-of-changes-in-stockholders-deficit-unaudited278F66D9-DE78-40CB-A225-99BEFEEEFF89 Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Statements 14 false false R15.htm 014 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.archtherapeutics.com/20220930/role/statement-consolidated-statements-of-cash-flows-unaudited3038549B-0871-42EA-B62B-4F52BADBED91 Consolidated Statements of Cash Flows (Unaudited) Statements 15 false false R16.htm 015 - Disclosure - Note 1 - Description of Business Sheet http://www.archtherapeutics.com/20220930/role/statement-note-1-description-of-business Note 1 - Description of Business Notes 16 false false R17.htm 016 - Disclosure - Note 2 - Summary Of Significant Accounting Policies Sheet http://www.archtherapeutics.com/20220930/role/statement-note-2-summary-of-significant-accounting-policies- Note 2 - Summary Of Significant Accounting Policies Notes 17 false false R18.htm 017 - Disclosure - Note 3 - Property and Equipment Sheet http://www.archtherapeutics.com/20220930/role/statement-note-3-property-and-equipment- Note 3 - Property and Equipment Notes 18 false false R19.htm 018 - Disclosure - Note 4 - Inventories Sheet http://www.archtherapeutics.com/20220930/role/statement-note-4-inventories- Note 4 - Inventories Notes 19 false false R20.htm 019 - Disclosure - Note 5 - Insurance Premium Financing Sheet http://www.archtherapeutics.com/20220930/role/statement-note-5-insurance-premium-financing Note 5 - Insurance Premium Financing Notes 20 false false R21.htm 020 - Disclosure - Note 6 - Registered Direct Offerings Sheet http://www.archtherapeutics.com/20220930/role/statement-note-6-registered-direct-offerings Note 6 - Registered Direct Offerings Notes 21 false false R22.htm 021 - Disclosure - Note 7 - Derivative Liabilities Sheet http://www.archtherapeutics.com/20220930/role/statement-note-7-derivative-liabilities Note 7 - Derivative Liabilities Notes 22 false false R23.htm 022 - Disclosure - Note 8 - October 2019 Registered Direct Offering Sheet http://www.archtherapeutics.com/20220930/role/statement-note-8-october-2019-registered-direct-offering Note 8 - October 2019 Registered Direct Offering Notes 23 false false R24.htm 023 - Disclosure - Note 9 - 2021 Registered Direct Offering Sheet http://www.archtherapeutics.com/20220930/role/statement-note-9-2021-registered-direct-offering Note 9 - 2021 Registered Direct Offering Notes 24 false false R25.htm 024 - Disclosure - Note 10 - 2022 Convertible Note Offering Sheet http://www.archtherapeutics.com/20220930/role/statement-note-10-2022-convertible-note-offering- Note 10 - 2022 Convertible Note Offering Notes 25 false false R26.htm 025 - Disclosure - Note 11 - Series 1 and Series 2 Convertible Notes Notes http://www.archtherapeutics.com/20220930/role/statement-note-11-series-1-and-series-2-convertible-notes Note 11 - Series 1 and Series 2 Convertible Notes Notes 26 false false R27.htm 026 - Disclosure - Note 12 - Income Taxes Sheet http://www.archtherapeutics.com/20220930/role/statement-note-12-income-taxes- Note 12 - Income Taxes Notes 27 false false R28.htm 027 - Disclosure - Note 13- Payroll Protection Program Loan Sheet http://www.archtherapeutics.com/20220930/role/statement-note-13-payroll-protection-program-loan Note 13- Payroll Protection Program Loan Notes 28 false false R29.htm 028 - Disclosure - Note 14 - Stock-based Compensation Sheet http://www.archtherapeutics.com/20220930/role/statement-note-14-stockbased-compensation Note 14 - Stock-based Compensation Notes 29 false false R30.htm 029 - Disclosure - Note 15 - Commitments and Contingencies Sheet http://www.archtherapeutics.com/20220930/role/statement-note-15-commitments-and-contingencies Note 15 - Commitments and Contingencies Notes 30 false false R31.htm 030 - Disclosure - Note 16 - Risks and Uncertainties - COVID-19 and Geopolitical Conflicts Sheet http://www.archtherapeutics.com/20220930/role/statement-note-16-risks-and-uncertainties-covid19-and-geopolitical-conflicts Note 16 - Risks and Uncertainties - COVID-19 and Geopolitical Conflicts Notes 31 false false R32.htm 031 - Disclosure - Note 1 - Basis of Presentation and Description of Business Sheet http://www.archtherapeutics.com/20220930/role/statement-note-1-basis-of-presentation-and-description-of-business Note 1 - Basis of Presentation and Description of Business Notes 32 false false R33.htm 032 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.archtherapeutics.com/20220930/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 33 false false R34.htm 033 - Disclosure - Note 3 - Property and Equipment (10Q) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-3-property-and-equipment-10q Note 3 - Property and Equipment (10Q) Notes 34 false false R35.htm 034 - Disclosure - Note 4 - Inventories (10Q) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-4-inventories-10q Note 4 - Inventories (10Q) Notes 35 false false R36.htm 035 - Disclosure - Note 5 - Insurance Premium Financing Sheet http://www.archtherapeutics.com/20220930/role/statement-note-5-insurance-premium-financingAF17A54B-59FA-4DD7-A3EE-937FDECFC24A Note 5 - Insurance Premium Financing Notes 36 false false R37.htm 036 - Disclosure - Note 6 - Stock-based Compensation Sheet http://www.archtherapeutics.com/20220930/role/statement-note-6-stockbased-compensation Note 6 - Stock-based Compensation Notes 37 false false R38.htm 037 - Disclosure - Note 7 - Registered Direct Offerings Sheet http://www.archtherapeutics.com/20220930/role/statement-note-7-registered-direct-offerings Note 7 - Registered Direct Offerings Notes 38 false false R39.htm 038 - Disclosure - Note 8 - Derivative Liabilities Sheet http://www.archtherapeutics.com/20220930/role/statement-note-8-derivative-liabilities Note 8 - Derivative Liabilities Notes 39 false false R40.htm 039 - Disclosure - Note 9 - October 2019 Registered Direct Offering Sheet http://www.archtherapeutics.com/20220930/role/statement-note-9-october-2019-registered-direct-offering Note 9 - October 2019 Registered Direct Offering Notes 40 false false R41.htm 040 - Disclosure - Note 10 - 2021 Registered Direct Offerings Sheet http://www.archtherapeutics.com/20220930/role/statement-note-10-2021-registered-direct-offerings Note 10 - 2021 Registered Direct Offerings Notes 41 false false R42.htm 041 - Disclosure - Note 11 - 2022 Convertible Note Offering, Second Notes Offering, and Third Notes Offering Notes http://www.archtherapeutics.com/20220930/role/statement-note-11-2022-convertible-note-offering-second-notes-offering-and-third-notes-offering Note 11 - 2022 Convertible Note Offering, Second Notes Offering, and Third Notes Offering Notes 42 false false R43.htm 042 - Disclosure - Note 12 - Series Convertible Notes Notes http://www.archtherapeutics.com/20220930/role/statement-note-12-series-convertible-notes Note 12 - Series Convertible Notes Notes 43 false false R44.htm 043 - Disclosure - Note 13 - Risks and Uncertainties - COVID-19 and Geopolitical Conflicts Sheet http://www.archtherapeutics.com/20220930/role/statement-note-13-risks-and-uncertainties-covid19-and-geopolitical-conflicts Note 13 - Risks and Uncertainties - COVID-19 and Geopolitical Conflicts Notes 44 false false R45.htm 044 - Disclosure - Note 14 - Shareholder Advances and Prefundings Related to The Anticipated Bridge Financing Sheet http://www.archtherapeutics.com/20220930/role/statement-note-14-shareholder-advances-and-prefundings-related-to-the-anticipated-bridge-financing Note 14 - Shareholder Advances and Prefundings Related to The Anticipated Bridge Financing Notes 45 false false R46.htm 045 - Disclosure - Note 15 - Subsequent Events Sheet http://www.archtherapeutics.com/20220930/role/statement-note-15-subsequent-events Note 15 - Subsequent Events Notes 46 false false R47.htm 046 - Disclosure - Note 3 - Property and Equipment (Tables) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-3-property-and-equipment-tables Note 3 - Property and Equipment (Tables) Tables http://www.archtherapeutics.com/20220930/role/statement-note-3-property-and-equipment- 47 false false R48.htm 047 - Disclosure - Note 4 - Inventories (Tables) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-4-inventories-tables Note 4 - Inventories (Tables) Tables http://www.archtherapeutics.com/20220930/role/statement-note-4-inventories- 48 false false R49.htm 048 - Disclosure - Note 7 - Derivative Liabilities (Tables) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-7-derivative-liabilities-tables Note 7 - Derivative Liabilities (Tables) Tables http://www.archtherapeutics.com/20220930/role/statement-note-7-derivative-liabilities 49 false false R50.htm 049 - Disclosure - Note 10 - 2022 Convertible Note Offering (Tables) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-10-2022-convertible-note-offering-tables Note 10 - 2022 Convertible Note Offering (Tables) Tables http://www.archtherapeutics.com/20220930/role/statement-note-10-2022-convertible-note-offering- 50 false false R51.htm 050 - Disclosure - Note 12 - Income Taxes (Tables) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-12-income-taxes-tables Note 12 - Income Taxes (Tables) Tables http://www.archtherapeutics.com/20220930/role/statement-note-12-income-taxes- 51 false false R52.htm 051 - Disclosure - Note 14 - Stock-based Compensation (Tables) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-14-stockbased-compensation-tables Note 14 - Stock-based Compensation (Tables) Tables http://www.archtherapeutics.com/20220930/role/statement-note-14-stockbased-compensation 52 false false R53.htm 052 - Disclosure - Note 3 - Property and Equipment (10Q) (Tables) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-3-property-and-equipment-10q-tables Note 3 - Property and Equipment (10Q) (Tables) Tables http://www.archtherapeutics.com/20220930/role/statement-note-3-property-and-equipment- 53 false false R54.htm 053 - Disclosure - Note 4 - Inventories (10Q) (Tables) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-4-inventories-10q-tables Note 4 - Inventories (10Q) (Tables) Tables http://www.archtherapeutics.com/20220930/role/statement-note-4-inventories- 54 false false R55.htm 054 - Disclosure - Note 6 - Stock-based Compensation (Tables) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-6-stockbased-compensation-tables Note 6 - Stock-based Compensation (Tables) Tables http://www.archtherapeutics.com/20220930/role/statement-note-6-stockbased-compensation 55 false false R56.htm 055 - Disclosure - Note 8 - Derivative Liabilities (Tables) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-8-derivative-liabilities-tables Note 8 - Derivative Liabilities (Tables) Tables http://www.archtherapeutics.com/20220930/role/statement-note-8-derivative-liabilities 56 false false R57.htm 056 - Disclosure - Note 11 - 2022 Convertible Note Offering, Second Notes Offering, and Third Notes Offering (Tables) Notes http://www.archtherapeutics.com/20220930/role/statement-note-11-2022-convertible-note-offering-second-notes-offering-and-third-notes-offering-tables Note 11 - 2022 Convertible Note Offering, Second Notes Offering, and Third Notes Offering (Tables) Tables http://www.archtherapeutics.com/20220930/role/statement-note-11-2022-convertible-note-offering-second-notes-offering-and-third-notes-offering 57 false false R58.htm 057 - Disclosure - Note 1 - Description of Business (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-1-description-of-business-details-textual Note 1 - Description of Business (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-1-description-of-business 58 false false R59.htm 058 - Disclosure - Note 3 - Property and Equipment (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-3-property-and-equipment-details-textual Note 3 - Property and Equipment (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-3-property-and-equipment-tables 59 false false R60.htm 059 - Disclosure - Note 3 - Property and Equipment - Property and Equipment (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-3-property-and-equipment-property-and-equipment-details Note 3 - Property and Equipment - Property and Equipment (Details) Details 60 false false R61.htm 060 - Disclosure - Note 5 - Inventories - Inventories (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-5-inventories-inventories-details Note 5 - Inventories - Inventories (Details) Details 61 false false R62.htm 061 - Disclosure - Note 5 - Insurance Premium Financing (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-5-insurance-premium-financing-details-textual Note 5 - Insurance Premium Financing (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-5-insurance-premium-financing 62 false false R63.htm 062 - Disclosure - Note 6 - Registered Direct Offerings (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-6-registered-direct-offerings-details-textual Note 6 - Registered Direct Offerings (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-6-registered-direct-offerings 63 false false R64.htm 063 - Disclosure - Note 7 - Derivative Liabilities (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-7-derivative-liabilities-details-textual Note 7 - Derivative Liabilities (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-7-derivative-liabilities-tables 64 false false R65.htm 064 - Disclosure - Note 7 - Derivative Liabilities - Fair Value of Derivative Liability (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-7-derivative-liabilities-fair-value-of-derivative-liability-details Note 7 - Derivative Liabilities - Fair Value of Derivative Liability (Details) Details 65 false false R66.htm 065 - Disclosure - Note 7 - Derivative Liabilities - Derivative Liability Value Assumptions (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-7-derivative-liabilities-derivative-liability-value-assumptions-details Note 7 - Derivative Liabilities - Derivative Liability Value Assumptions (Details) Details 66 false false R67.htm 066 - Disclosure - Note 8 - October 2019 Registered Direct Offering (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-8-october-2019-registered-direct-offering-details-textual Note 8 - October 2019 Registered Direct Offering (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-8-october-2019-registered-direct-offering 67 false false R68.htm 067 - Disclosure - Note 9 - 2021 Registered Direct Offering (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-9-2021-registered-direct-offering-details-textual Note 9 - 2021 Registered Direct Offering (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-9-2021-registered-direct-offering 68 false false R69.htm 068 - Disclosure - Note 10 - 2022 Convertible Note Offering (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-10-2022-convertible-note-offering-details-textual Note 10 - 2022 Convertible Note Offering (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-10-2022-convertible-note-offering-tables 69 false false R70.htm 069 - Disclosure - Note 11 - 2022 Convertible Note Offering - Summary of Valuation Assumptions for Warrants (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-11-2022-convertible-note-offering-summary-of-valuation-assumptions-for-warrants-details Note 11 - 2022 Convertible Note Offering - Summary of Valuation Assumptions for Warrants (Details) Details 70 false false R71.htm 070 - Disclosure - Note 11 - Series 1 and Series 2 Convertible Notes (Details Textual) Notes http://www.archtherapeutics.com/20220930/role/statement-note-11-series-1-and-series-2-convertible-notes-details-textual Note 11 - Series 1 and Series 2 Convertible Notes (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-11-series-1-and-series-2-convertible-notes 71 false false R72.htm 071 - Disclosure - Note 12 - Income Taxes (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-12-income-taxes-details-textual Note 12 - Income Taxes (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-12-income-taxes-tables 72 false false R73.htm 072 - Disclosure - Note 12 - Income Taxes - Net Deferred Tax Assets (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-12-income-taxes-net-deferred-tax-assets-details Note 12 - Income Taxes - Net Deferred Tax Assets (Details) Details 73 false false R74.htm 073 - Disclosure - Note 12 - Income Taxes - Computation of Provision (benefits) Income Taxes from Statutory Federal Income Tax Rate (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-12-income-taxes-computation-of-provision-benefits-income-taxes-from-statutory-federal-income-tax-rate-details Note 12 - Income Taxes - Computation of Provision (benefits) Income Taxes from Statutory Federal Income Tax Rate (Details) Details 74 false false R75.htm 074 - Disclosure - Note 13- Payroll Protection Program Loan (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-13-payroll-protection-program-loan-details-textual Note 13- Payroll Protection Program Loan (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-13-payroll-protection-program-loan 75 false false R76.htm 075 - Disclosure - Note 14 - Stock-based Compensation (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-14-stockbased-compensation-details-textual Note 14 - Stock-based Compensation (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-14-stockbased-compensation-tables 76 false false R77.htm 076 - Disclosure - Note 14 - Stock-based Compensation - Stock Compensation Activity (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-14-stockbased-compensation-stock-compensation-activity-details Note 14 - Stock-based Compensation - Stock Compensation Activity (Details) Details 77 false false R78.htm 077 - Disclosure - Note 14 - Stock-based Compensation - Restricted Stock Activity (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-14-stockbased-compensation-restricted-stock-activity-details Note 14 - Stock-based Compensation - Restricted Stock Activity (Details) Details 78 false false R79.htm 078 - Disclosure - Note 14 - Stock-based Compensation - Restricted Stock Weighted Average Grant Date Fair Value (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-14-stockbased-compensation-restricted-stock-weighted-average-grant-date-fair-value-details Note 14 - Stock-based Compensation - Restricted Stock Weighted Average Grant Date Fair Value (Details) Details 79 false false R80.htm 079 - Disclosure - Note 15 - Commitments and Contingencies (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-15-commitments-and-contingencies-details-textual Note 15 - Commitments and Contingencies (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-15-commitments-and-contingencies 80 false false R81.htm 080 - Disclosure - Note 1 - Basis of Presentation and Description of Business (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-1-basis-of-presentation-and-description-of-business-details-textual Note 1 - Basis of Presentation and Description of Business (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-1-basis-of-presentation-and-description-of-business 81 false false R82.htm 081 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-2-summary-of-significant-accounting-policies 82 false false R83.htm 082 - Disclosure - Note 3 - Property and Equipment (10Q) (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-3-property-and-equipment-10q-details-textual Note 3 - Property and Equipment (10Q) (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-3-property-and-equipment-tables 83 false false R84.htm 083 - Disclosure - Note 3 - Property and Equipment - Property and Equipment (10Q) (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-3-property-and-equipment-property-and-equipment-10q-details Note 3 - Property and Equipment - Property and Equipment (10Q) (Details) Details 84 false false R85.htm 084 - Disclosure - Note 4 - Inventories - Inventories (10Q) (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-4-inventories-inventories-10q-details Note 4 - Inventories - Inventories (10Q) (Details) Details 85 false false R86.htm 085 - Disclosure - Note 5 - Insurance Premium Financing (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-5-insurance-premium-financing-details-textual24A8C8DA-32FA-4B78-B6C6-C5C9EA5DA0C9 Note 5 - Insurance Premium Financing (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-5-insurance-premium-financing 86 false false R87.htm 086 - Disclosure - Note 6 - Stock-based Compensation (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-6-stockbased-compensation-details-textual Note 6 - Stock-based Compensation (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-6-stockbased-compensation-tables 87 false false R88.htm 087 - Disclosure - Note 6 - Stock-based Compensation - Stock Compensation Activity (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-6-stockbased-compensation-stock-compensation-activity-details Note 6 - Stock-based Compensation - Stock Compensation Activity (Details) Details 88 false false R89.htm 088 - Disclosure - Note 6 - Stock-based Compensation - Restricted Stock Activity (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-6-stockbased-compensation-restricted-stock-activity-details Note 6 - Stock-based Compensation - Restricted Stock Activity (Details) Details 89 false false R90.htm 089 - Disclosure - Note 6 - Stock-based Compensation - Restricted Stock Weighted Average Grant Date Fair Value (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement--note-6-stockbased-compensation-restricted-stock-weighted-average-grant-date-fair-value-details Note 6 - Stock-based Compensation - Restricted Stock Weighted Average Grant Date Fair Value (Details) Details 90 false false R91.htm 090 - Disclosure - Note 7 - Registered Direct Offerings (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-7-registered-direct-offerings-details-textual Note 7 - Registered Direct Offerings (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-7-registered-direct-offerings 91 false false R92.htm 091 - Disclosure - Note 8 - Derivative Liabilities (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-8-derivative-liabilities-details-textual Note 8 - Derivative Liabilities (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-8-derivative-liabilities-tables 92 false false R93.htm 092 - Disclosure - Note 8 - Derivative Liabilities - Fair Value of Derivative Liability (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-8-derivative-liabilities-fair-value-of-derivative-liability-details Note 8 - Derivative Liabilities - Fair Value of Derivative Liability (Details) Details 93 false false R94.htm 093 - Disclosure - Note 8 - Derivative Liabilities - Derivative Liability Value Assumptions (Details) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-8-derivative-liabilities-derivative-liability-value-assumptions-details Note 8 - Derivative Liabilities - Derivative Liability Value Assumptions (Details) Details 94 false false R95.htm 094 - Disclosure - Note 9 - October 2019 Registered Direct Offering (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-9-october-2019-registered-direct-offering-details-textual Note 9 - October 2019 Registered Direct Offering (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-9-october-2019-registered-direct-offering 95 false false R96.htm 095 - Disclosure - Note 10 - 2021 Registered Direct Offerings (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-10-2021-registered-direct-offerings-details-textual Note 10 - 2021 Registered Direct Offerings (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-10-2021-registered-direct-offerings 96 false false R97.htm 096 - Disclosure - Note 11 - 2022 Convertible Note Offering, Second Notes Offering, and Third Notes Offering (Details Textual) Notes http://www.archtherapeutics.com/20220930/role/statement-note-11-2022-convertible-note-offering-second-notes-offering-and-third-notes-offering-details-textual Note 11 - 2022 Convertible Note Offering, Second Notes Offering, and Third Notes Offering (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-11-2022-convertible-note-offering-second-notes-offering-and-third-notes-offering-tables 97 false false R98.htm 097 - Disclosure - Note 11 - 2022 Convertible Note Offering and Second Notes Offering - Summary of Valuation Assumptions for Warrants (Details) Notes http://www.archtherapeutics.com/20220930/role/statement-note-11-2022-convertible-note-offering-and-second-notes-offering-summary-of-valuation-assumptions-for-warrants-details Note 11 - 2022 Convertible Note Offering and Second Notes Offering - Summary of Valuation Assumptions for Warrants (Details) Details 98 false false R99.htm 098 - Disclosure - Note 12 - Series Convertible Notes (Details Textual) Notes http://www.archtherapeutics.com/20220930/role/statement-note-12-series-convertible-notes-details-textual Note 12 - Series Convertible Notes (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-12-series-convertible-notes 99 false false R100.htm 099 - Disclosure - Note 14 - Shareholder Advances and Prefundings Related to The Anticipated Bridge Financing (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-14-shareholder-advances-and-prefundings-related-to-the-anticipated-bridge-financing-details-textual Note 14 - Shareholder Advances and Prefundings Related to The Anticipated Bridge Financing (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-14-shareholder-advances-and-prefundings-related-to-the-anticipated-bridge-financing 100 false false R101.htm 100 - Disclosure - Note 15 - Subsequent Events (Details Textual) Sheet http://www.archtherapeutics.com/20220930/role/statement-note-15-subsequent-events-details-textual Note 15 - Subsequent Events (Details Textual) Details http://www.archtherapeutics.com/20220930/role/statement-note-15-subsequent-events 101 false false All Reports Book All Reports arch-20220930.xsd arch-20220930_cal.xml arch-20220930_def.xml arch-20220930_lab.xml arch-20220930_pre.xml arch20230928_s1a.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true